InvestorsHub Logo
Followers 2
Posts 118
Boards Moderated 0
Alias Born 05/31/2011

Re: Lady_luck post# 25260

Monday, 12/03/2018 8:25:04 PM

Monday, December 03, 2018 8:25:04 PM

Post# of 34624
Curious on updates for tonight’s presentation. If anyone has links or updates, please provide.

Thanks!

1014 Safety and Efficacy of Multiantigen-Targeted T Cells for Multiple Myeloma
Program: Oral and Poster Abstracts
Type: Oral
Session: 653. Myeloma: Therapy, excluding Transplantation: Immunotherapy
Hematology Disease Topics & Pathways:
Biological, multiple myeloma, viral, Diseases, Therapies, immunotherapy, Plasma Cell Disorders, Clinically relevant, Lymphoid Malignancies
Monday, December 3, 2018: 7:30 PM

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News